Novonesis (Novozymes) B
NSISBC
Rang in Aktien
#1153
Established in January 2024 through the amalgamation of Novozymes A/S and Chr.... Established in January 2024 through the amalgamation of Novozymes A/S and Chr. Hansen, Novonesis now stands as a prominent global leader in biosolutions. The firm's activities encompass the worldwide development and commercialization of industrial enzymes, diverse microorganisms, and vital biopharmaceutical ingredients. Distinctively, its Class B shares are listed independently and actively traded on various European exchanges.
Aktienkurs
$70.19
Marktkapitalisierung
$19.51B
Veränderung (1 Tag)
0.13%
Veränderung (1 Jahr)
10.71%
Land
DK
Handel Novonesis (Novozymes) B (NSISBC)
Kategorie
Basic Materials
Kursverlauf für Novonesis (Novozymes) B (NSISBC)
Höchster Schlusskurs: $69.75 am 2026-10-01
Niedrigster Schlusskurs: $58.74 am 2024-03-01
Niedrigster Schlusskurs: $58.74 am 2024-03-01
Kursverlauf der Aktie von Novonesis (Novozymes) B von 2024 bis 2026
Jährliche Kursentwicklung
| Jahr | Leistung |
|---|---|
| 2026 (TTM) | 1.88% |
| 2025 | 7.42% |
| 2024 | 0.00% |
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Aktienkurs | Veränderung 1J% | Land |
|---|---|---|---|
| $498.80 | 10.86% |
GB
|
|
| $193.41 | 6.27% |
FR
|
|
| $337.21 | 1.02% |
US
|
|
| $287.77 | 4.26% |
US
|
|
| $302.56 | 19.52% |
US
|
